D. Kingston

Journal of Natural Products · 2008

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom D. Kingston trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Butler

Papers from D. Kingston's perspective

Ordered by how strongly the researchers D. Kingston trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Albumin-bound paclitaxel: a next-generation taxane (Expert Opinion on Pharmacotherapy)
  2. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor‐targeted drug delivery vectors
  3. Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery (Drug Delivery)
  4. Lessons from natural molecules (Nature)
  5. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries (Ca)
  6. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial… (Journal of Clinical Oncology)
  7. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (New England Journal of Medicine)
  8. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of… (Annals of Oncology)
  9. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years (New England Journal of Medicine)
  10. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. (Clinical Cancer Research)

Their papers